Sander van Deventer - Chief Executive Officer @ VectorY

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

Number of Founded Organizations

Primary Job Title Chief Executive Officer
Primary Organization
VectorY

Location Naarden, Noord-Holland, The Netherlands
Regions European Union (EU), Europe, Middle East, and Africa (EMEA)
Gender Male

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn

Sander van Deventer is the Chief Executive Officer of VectorY. He previously worked at Porton Biologics Ltd. as a Chief Scientific Officer. Sander van Deventer attended the University of Amsterdam.

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	CoviCept Therapeutics	Forbion Capital Partners	Yes	Seed Round - CoviCept Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Hookipa Pharma	Forbion Capital Partners	—	Series C - Hookipa Pharma	obfuscated obfuscation
obfuscated obfuscation	Hookipa Pharma	Forbion Capital Partners	Yes	Series B - Hookipa Pharma	obfuscated obfuscation
obfuscated obfuscation	Argos Therapeutics	Forbion Capital Partners	Yes	Series D - Argos Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Hookipa Pharma	Forbion Capital Partners	—	Series A - Hookipa Pharma	obfuscated obfuscation
obfuscated obfuscation	gIcare Pharma	Forbion Capital Partners	Yes	Series A - gIcare Pharma	obfuscated obfuscation
obfuscated obfuscation	Cardoz	Forbion Capital Partners	Yes	Series A - Cardoz	obfuscated obfuscation

Jobs

Number of Current Jobs

Number of Past Jobs

Sander van Deventer

has

current jobs including

Chief Executive Officer

VectorY

CSO

Porton Advanced Solutions

, and

Co-Owner

VISKERcycles

. Additionally,

Sander van Deventer

has had

past jobs including

Co-Founder and Chief Technology Officer

VectorY

VectorY Chief Executive OfficerNov 2022
Porton Advanced Solutions CSOAug 2020
VISKERcycles Co-OwnerAug 2019
Forbion Capital Partners Operating PartnerAug 2017
Leiden University Professor of Translational Gastroenterology

Organization Name	Title At Company	Start Date	End Date
VectorY	Co-Founder and Chief Technology Officer	Jun 2021	Nov 2022
The Rockefeller University	Scientist	—	—

Board and Advisor Roles

Number of Current Board & Advisor Roles

Sander van Deventer

holds

board and advisor roles including

Chief Scientific Officer, General Manager

UniQure

Board Member

Argos Therapeutics

, and

Board of Directors

Cardoz

UniQure Chief Scientific Officer, General ManagerAug 2017
Argos Therapeutics Board Member2001
Cardoz Board of Directors
Hookipa Pharma Board of Directors
NovImmune Scientific Advisory Board
gIcare Pharma Board of Directors

Related Hubs

Hub Name	CB Rank (Hub)
European Union (EU) Therapeutics Female Founded Companies	67,687
The Netherlands Startups Founded in 2020	76,199
EQT Life Sciences Portfolio Companies	94,579
The Netherlands Therapeutics Companies	58,913
Noord-Holland Companies With Fewer Than 1000 Employees (Top 10K)	11,342
Therapeutics Early Stage Companies With Fewer Than 1000 Employees	52,081
Europe Therapeutics Companies	9,042
Europe Female Founded Companies with Early Stage Venture Funding	44,874
European Union (EU) Health Care Companies with Early Stage Venture Funding	64,443
Forbion Capital Partners Portfolio Companies	86,423